Sponsor

The Novo Nordisk Foundation Center for Basic Metabolic Research

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name The Novo Nordisk Foundation Center for Basic Metabolic Research appears in 13 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials13
Recruiting shown2
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

13 shown
A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 DiabetesNCT07262788 · collaborator · 2025-09-30
RECRUITING
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive FactorsNCT04916132 · collaborator · 2021-08-10
RECRUITING
Mapping the Human Appendix Using Single Cell SequencingNCT05209061 · collaborator · 2023-02-01
COMPLETED
Neuronostatin - a Glucagonotropic Agent in Humans?NCT06143267 · collaborator · 2022-12-06
COMPLETED
The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 DiabetesNCT06137586 · collaborator · 2022-08-10
COMPLETED
Mapping the Human Colon Using Single Cell SequencingNCT05195502 · collaborator · 2022-07-01
COMPLETED
The Effect on Metabolism, Food Intake and Preferences of a Knockout Gene Variant Involved in Carbohydrate MetabolismNCT05375656 · collaborator · 2022-01-08
COMPLETED
Twenty-year Follow-up of the Inter99 CohortNCT05166447 · collaborator · 2021-09-13
ENROLLING_BY_INVITATION
Surgical Innovation for Diabetes Treatment 2NCT04712409 · collaborator · 2020-08-16
UNKNOWN
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationNCT03866421 · collaborator · 2019-05-29
TERMINATED
Surgical Innovation for Diabetes TreatmentNCT04196348 · collaborator · 2019-03-28
UNKNOWN
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced DiabetesNCT01795248 · collaborator · 2012-07-01
COMPLETED
Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for OverweightNCT00823277 · collaborator · 2009-01-01
COMPLETED

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing The Novo Nordisk Foundation Center for Basic Metabolic Research as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
liraglutide1
placebo1

Sponsor roles

collaborator13
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.